IL53520A0 - 5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their production - Google Patents
5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their productionInfo
- Publication number
- IL53520A0 IL53520A0 IL53520A IL5352077A IL53520A0 IL 53520 A0 IL53520 A0 IL 53520A0 IL 53520 A IL53520 A IL 53520A IL 5352077 A IL5352077 A IL 5352077A IL 53520 A0 IL53520 A0 IL 53520A0
- Authority
- IL
- Israel
- Prior art keywords
- oxazolidinones
- production
- substituted phenyl
- sulphur analogues
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762655369 DE2655369A1 (en) | 1976-12-03 | 1976-12-03 | 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION |
| DE19772745320 DE2745320A1 (en) | 1977-10-05 | 1977-10-05 | 5-Alkoxyphenyl-oxazolidine-2-one and sulphur analogues - useful as neuroleptics and phospho-di:esterase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL53520A0 true IL53520A0 (en) | 1978-03-10 |
| IL53520A IL53520A (en) | 1981-07-31 |
Family
ID=25771221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL53520A IL53520A (en) | 1976-12-03 | 1977-12-02 | Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5382777A (en) |
| AT (1) | AT357529B (en) |
| AU (1) | AU519994B2 (en) |
| CA (1) | CA1097657A (en) |
| CH (1) | CH635578A5 (en) |
| CS (1) | CS199694B2 (en) |
| DD (1) | DD133667A5 (en) |
| DK (1) | DK149850C (en) |
| FR (1) | FR2372814A1 (en) |
| GB (1) | GB1588639A (en) |
| GR (1) | GR64964B (en) |
| HU (1) | HU175676B (en) |
| IE (1) | IE46435B1 (en) |
| IL (1) | IL53520A (en) |
| IT (1) | IT1089341B (en) |
| LU (1) | LU78616A1 (en) |
| NL (1) | NL7713153A (en) |
| SE (1) | SE441446B (en) |
| SU (1) | SU888821A3 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2701215C2 (en) * | 1977-01-13 | 1982-10-14 | Bayer Ag, 5090 Leverkusen | Process for the preparation of thiazoline-2-thiones |
| US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
| DE3438839A1 (en) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | PHARMACEUTICAL PREPARATIONS |
| WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| JPH01135098U (en) * | 1988-03-11 | 1989-09-14 | ||
| WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| US5461056A (en) * | 1992-05-08 | 1995-10-24 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
| GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
| GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
| US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
| ATE260911T1 (en) * | 1993-12-22 | 2004-03-15 | Celltech R&D Ltd | TRISUBSUTITUTED PHENYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PHOSPHODIESTERASE (TYPE IV) INHIBITORS |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412571D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
| AU5330698A (en) * | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9705361D0 (en) | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
1977
- 1977-11-28 SU SU772546252A patent/SU888821A3/en active
- 1977-11-29 NL NL7713153A patent/NL7713153A/en not_active Application Discontinuation
- 1977-12-01 LU LU78616A patent/LU78616A1/xx unknown
- 1977-12-01 SE SE7713635A patent/SE441446B/en not_active IP Right Cessation
- 1977-12-01 DD DD7700202354A patent/DD133667A5/en unknown
- 1977-12-01 IT IT30254/77A patent/IT1089341B/en active
- 1977-12-02 CH CH1477977A patent/CH635578A5/en not_active IP Right Cessation
- 1977-12-02 IL IL53520A patent/IL53520A/en unknown
- 1977-12-02 DK DK536677A patent/DK149850C/en not_active IP Right Cessation
- 1977-12-02 HU HU77SCHE632A patent/HU175676B/en not_active IP Right Cessation
- 1977-12-02 JP JP14492277A patent/JPS5382777A/en active Granted
- 1977-12-02 CA CA292,273A patent/CA1097657A/en not_active Expired
- 1977-12-02 IE IE2446/77A patent/IE46435B1/en not_active IP Right Cessation
- 1977-12-02 AU AU31175/77A patent/AU519994B2/en not_active Expired
- 1977-12-02 GB GB50350/77A patent/GB1588639A/en not_active Expired
- 1977-12-02 GR GR54913A patent/GR64964B/en unknown
- 1977-12-05 AT AT868677A patent/AT357529B/en not_active IP Right Cessation
- 1977-12-05 FR FR7736525A patent/FR2372814A1/en active Granted
- 1977-12-05 CS CS778086A patent/CS199694B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1089341B (en) | 1985-06-18 |
| SU888821A3 (en) | 1981-12-07 |
| FR2372814A1 (en) | 1978-06-30 |
| AT357529B (en) | 1980-07-10 |
| GR64964B (en) | 1980-06-10 |
| IE46435B1 (en) | 1983-06-15 |
| DK149850B (en) | 1986-10-13 |
| SE441446B (en) | 1985-10-07 |
| IE772446L (en) | 1978-06-03 |
| NL7713153A (en) | 1978-06-06 |
| AU519994B2 (en) | 1982-01-07 |
| GB1588639A (en) | 1981-04-29 |
| FR2372814B1 (en) | 1980-10-10 |
| AU3117577A (en) | 1979-06-07 |
| DD133667A5 (en) | 1979-01-17 |
| CS199694B2 (en) | 1980-07-31 |
| JPS6154792B2 (en) | 1986-11-25 |
| JPS5382777A (en) | 1978-07-21 |
| IL53520A (en) | 1981-07-31 |
| LU78616A1 (en) | 1978-04-20 |
| CH635578A5 (en) | 1983-04-15 |
| DK149850C (en) | 1987-04-27 |
| SE7713635L (en) | 1978-06-04 |
| ATA868677A (en) | 1979-12-15 |
| CA1097657A (en) | 1981-03-17 |
| DK536677A (en) | 1978-06-04 |
| HU175676B (en) | 1980-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL53520A0 (en) | 5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their production | |
| JPS5353595A (en) | Production of sulfur | |
| JPS52100461A (en) | Ploline related compound and production thereof | |
| JPS565305A (en) | Production of sulfur | |
| ZA776431B (en) | Process for oxidizing sulfur and sulfur compounds | |
| JPS5325666A (en) | Self swelling waterstopping material production method | |
| BG28561A3 (en) | Production | |
| JPS52113959A (en) | Production of aryll33 oxazolidinone | |
| JPS5318497A (en) | Process for preparing low sulphur chromiumoxide*3* | |
| PH14425A (en) | A process of preparing n-substituted biscarbamoyl sulfide compounds | |
| JPS5350129A (en) | Aryl sulfur compound | |
| JPS5334901A (en) | Production of leather | |
| JPS536331A (en) | Process for manufacture of 2*55biss*benzz oxazolil**thiophene compound | |
| IL52032A (en) | Propane-1,2-dione-dioxime carbamates,a process for their manufacture and insecticidal compositions containing them | |
| NZ183045A (en) | Aminocylol production | |
| JPS52122691A (en) | Production of 33 carbamoyloxymethylcephalosporin | |
| JPS5381662A (en) | Production of material for confectionery | |
| JPS5381663A (en) | Production of material for confectionery | |
| JPS5362831A (en) | Production of pesticidal apparatus | |
| JPS52136126A (en) | Process for manufacturing methyl chloroformate | |
| GB1524782A (en) | Production of estertype polyols | |
| JPS5359658A (en) | Production of 33 acylaminoazetidinee22 one | |
| ZA776989B (en) | A caustic-free process for the production of monochloro-diamino-s-triazines | |
| JPS5323324A (en) | Production method of fireerestant material | |
| JPS52105149A (en) | Substituted phenyl guanidine and process for manufacture thereof |